Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123381052 | 12338105 | 2 | F | 20160404 | 20160512 | 20160505 | 20160711 | PER | US-ASTRAZENECA-2016SE41867 | ASTRAZENECA | 19738.00 | DY | F | Y | 108.90000 | KG | 20160712 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123381052 | 12338105 | 1 | PS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | PAKK | 21949 | 180 | UG | INHALATION POWDER | BID | ||||||
123381052 | 12338105 | 2 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | PAKK | 21949 | 180 | UG | INHALATION POWDER | BID | ||||||
123381052 | 12338105 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | BID | ||||||||
123381052 | 12338105 | 4 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | BID | ||||||||
123381052 | 12338105 | 5 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 0 | 100 | MG | BID | ||||||||
123381052 | 12338105 | 6 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | Oral | 10.0MG AS REQUIRED | 0 | 10 | MG | ||||||||
123381052 | 12338105 | 7 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
123381052 | 12338105 | 8 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
123381052 | 12338105 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 300 | MG | TID | ||||||||
123381052 | 12338105 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 AS REQUIRED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123381052 | 12338105 | 1 | Asthma |
123381052 | 12338105 | 2 | Gastrooesophageal reflux disease |
123381052 | 12338105 | 3 | Barrett's oesophagus |
123381052 | 12338105 | 4 | Depression |
123381052 | 12338105 | 5 | Fibromyalgia |
123381052 | 12338105 | 6 | Constipation |
123381052 | 12338105 | 7 | Multiple allergies |
123381052 | 12338105 | 8 | Muscle spasms |
123381052 | 12338105 | 9 | Fibromyalgia |
123381052 | 12338105 | 10 | Asthma |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123381052 | 12338105 | Drug ineffective | |
123381052 | 12338105 | Off label use | |
123381052 | 12338105 | Product quality issue | |
123381052 | 12338105 | Product use issue | |
123381052 | 12338105 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123381052 | 12338105 | 1 | 20160404 | 0 | ||
123381052 | 12338105 | 2 | 20160404 | 0 | ||
123381052 | 12338105 | 3 | 1995 | 0 | ||
123381052 | 12338105 | 4 | 1995 | 0 | ||
123381052 | 12338105 | 5 | 2004 | 0 | ||
123381052 | 12338105 | 6 | 201601 | 0 | ||
123381052 | 12338105 | 7 | 2006 | 0 | ||
123381052 | 12338105 | 8 | 2006 | 0 | ||
123381052 | 12338105 | 9 | 2010 | 0 | ||
123381052 | 12338105 | 10 | 201512 | 0 |